DaVita Venture Group

Pathalys Pharma is a biopharmaceutical company dedicated to developing therapeutics for late-stage chronic kidney diseases. Its primary focus is improving treatment for secondary hyperparathyroidism, an unmet need in healthcare.

Xeltis is a clinical-stage medical device company developing bio-absorbable heart valves and blood vessels. Its RestoreX technology enables the body's natural healing system to create functional tissue within its devices, forming new valves or vessels over time. Headquartered in Zurich, Switzerland, with R&D and manufacturing facilities in Eindhoven, Netherlands, Xeltis aims to transform cardiovascular care.

Dock Health is a healthcare-focused productivity platform that provides HIPAA-compliant task management and collaboration tools for clinicians and care teams. The platform aims to streamline workflows and reduce administrative burden by integrating with electronic health records and other clinical systems, enabling secure communication and coordinated care. It incorporates AI-driven insights to support decision making and operational efficiency, helping teams complete tasks more reliably and improve patient care quality. Founded in 2016, the company is headquartered in Boston, Massachusetts.

Xeltis is a clinical-stage medical device company developing bio-absorbable heart valves and blood vessels. Its RestoreX technology enables the body's natural healing system to create functional tissue within its devices, forming new valves or vessels over time. Headquartered in Zurich, Switzerland, with R&D and manufacturing facilities in Eindhoven, Netherlands, Xeltis aims to transform cardiovascular care.

Pathalys Pharma is a biopharmaceutical company dedicated to developing therapeutics for late-stage chronic kidney diseases. Its primary focus is improving treatment for secondary hyperparathyroidism, an unmet need in healthcare.

Pathalys Pharma is a biopharmaceutical company dedicated to developing therapeutics for late-stage chronic kidney diseases. Its primary focus is improving treatment for secondary hyperparathyroidism, an unmet need in healthcare.

Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in cardiology services. Founded in 2017, it provides virtual-first solutions for the prevention and management of cardiovascular disease. The company utilizes a data-powered platform to facilitate real-time consultations between patients and physicians, enabling secure communication and collaboration on treatment and dietary advice. By offering tools that allow patients to monitor their heart health, Heartbeat Health aims to reduce cardiovascular risk and the likelihood of adverse health events. Its comprehensive approach enhances patient care and supports at-risk organizations through a focus on higher-value healthcare delivery.

NephroSant is an innovative diagnostic startup established by a team of physicians and experts in science, engineering, and clinical research, dedicated to enhancing global kidney health. The company has developed a urine-based diagnostic tool that enables the quantitative measurement of biomarkers crucial for the early detection and ongoing monitoring of kidney disease. This noninvasive tool is particularly valuable for physicians, as it aids in predicting and preventing the progression of kidney disease and facilitates the early detection of acute rejection in kidney transplant patients. Through their research-driven approach, NephroSant aims to significantly improve patient outcomes in kidney health.

SameSky Health specializes in multicultural patient engagement solutions. Its platform connects payers, providers, and health systems with diverse Medicare populations, offering multi-channel messaging, care navigation, data insights, and consultancy services to enhance engagement, reduce emergency room visits, and improve healthcare outcomes.

Wellth operates a mobile application that engages consumers in managing chronic diseases and fostering healthy habits. By providing targeted incentives, reminders, and information, Wellth aims to reduce healthcare costs by encouraging preventative actions and disease management.